AOS vs INM · P/E 19, rev $1.00B vs rev $4.9M
Smith AO Corporation (AOS) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. INM currently screens at market cap $5.2M.
Not investment advice. Open the AOS and INM stock pages for the full models.
Not investment advice.